Tumor infiltrating lymphocytes (TILs) as a predictive biomarker of response to checkpoint blockers in solid tumors: A systematic review-Reference-Cited by-同舟云学术

Tumor infiltrating lymphocytes (TILs) as a predictive biomarker of response to checkpoint blockers in solid tumors: A systematic review

Published:2022-09 Issue: Volume:177 Page:103773
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Presti Daniele,Dall’Olio Filippo Gustavo,Besse Benjamin,Ribeiro Joana Mourato,Di Meglio Antonio,Soldato Davide

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference105 articles.

1. Atezolizumab plus nab-paclitaxel in the treatment of metastatic triple-negative breast cancer with 2-year survival follow-up: a phase 1b clinical trial;Adams;JAMA Oncol.,2019

2. A multicenter phase II trial of ipilimumab and nivolumab in unresectable or metastatic metaplastic breast cancer: cohort 36 of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART, SWOG S1609);Adams;Clin. Cancer Res.,2021

3. Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy;Althammer;J. Immunother. Cancer,2019

4. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma;Amaria;Nat Med.,2018

5. Existing and emerging biomarkers for immune checkpoint immunotherapy in solid tumors;Arora;Adv. Ther.,2019

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of immune-checkpoint molecules in dMMR/pMMR colorectal cancer by multiplex immunohistochemistry;Clinical and Translational Oncology;2024-09-06

2. A Deep Learning Framework for Predicting Prognostically Relevant Consensus Molecular Subtypes in HPV-Positive Cervical Squamous Cell Carcinoma from Routine Histology Images;2024-08-19

3. High platelet - lymphocyte ratio may predict poor therapeutic response in breast cancer patients treated with neoadjuvant chemotherapy;2024-08-09

4. Predictors of response to immunotherapy in colorectal cancer;The Oncologist;2024-06-26

5. Merkel cell carcinoma - particularities and morphological aspect of a unique and rare entity;Acta Marisiensis - Seria Medica;2024-06-01